US2009298062A1PendingUtilityA1
Method for determination of the length of the g-tail sequence and kit for the method
Est. expirySep 21, 2025(expired)· nominal 20-yr term from priority
C12Q 1/6841C12Q 1/6827
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of measuring the length of a G tail sequence, characterized by hybridizing the G tail of an nondenatured chromosomal DNA in a sample with a labeled DNA probe having a sequence complementary to the telomere repeat sequence, measuring chemiluminescence from the hybridized DNA probe, and determining the length of the G tail sequence from the measured value, and a kit used for use in such a method.
Claims
exact text as granted — not AI-modified1 . A method of measuring the length of a G tail sequence, comprising hydrizing a G tail of an nondenatured chromosomal DNA in a sample with a labeled DNA probe having a sequence complementary to a telomere repeat sequence, measuring chemiluminescence from the hybridized DNA probe, and determining the length of the G tail sequence from the measured value.
2 . The method according to claim 1 , wherein the sample is a cell pellet of blood, a cultured cell, a fresh tissue, a cryopreserved tissue or a formalin-fixed tissue.
3 . The method according to claim 1 or 2 , wherein the fact that the chemiluminescence is based on the hybridization of the labeled DNA probe with the G tail sequence is confirmed by using an exonuclease.
4 . The method according to claim 3 , wherein the exonuclease is an exonuclease I.
5 . The method according to any one of claims 1 to 4 , wherein the label is an acridinium ester, luminol, isoluminol, pyrogallol, protohemin, aminobutylethyl-n-isoluminol or aminohexylethyl-n-ethyl-isoluminol.
6 . The method according to any one of claims 1 to 5 , wherein the sequence complementary to the telomere repeat sequence is a base sequence represented by (CCCTAA) n (n is an integer of 1 to 10).
7 . A kit for measuring the length of a G tail sequence, comprising at least a labeled DNA probe having a sequence complementary to an nondenatured telomere repeat sequence, a cytolytic solution, and a hydrolytic reagent.
8 . The kit according to claim 7 , further comprising an exonuclease as a confirming agent.
9 . The kit according to claim 7 or 8 , wherein the label is an acridinium ester, luminol, isoluminol, pyrogallol, protohemin, aminobutylethyl-n-isoluminol or aminohexylethyl-n-ethyl-isoluminol.
10 . The kit according to any one of claims 7 to 9 , wherein the sequence complementary to the telomere repeat sequence is a base sequence represented by (CCCTAA) n (n is an integer of 1 to 10).
11 . The method according to any one of claims 1 to 7 , wherein the sample is a human- or mouse-derived sample.Join the waitlist — get patent alerts
Track US2009298062A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.